Suppr超能文献

肿瘤和传染病中的免疫原性细胞死亡

Immunogenic cell death in cancer and infectious disease.

机构信息

Department of Radiation Oncology, Weill Cornell Medical College, 10065 New York, New York, USA.

Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, 75006 Paris, France.

出版信息

Nat Rev Immunol. 2017 Feb;17(2):97-111. doi: 10.1038/nri.2016.107. Epub 2016 Oct 17.

Abstract

Immunogenicity depends on two key factors: antigenicity and adjuvanticity. The presence of exogenous or mutated antigens explains why infected cells and malignant cells can initiate an adaptive immune response provided that the cells also emit adjuvant signals as a consequence of cellular stress and death. Several infectious pathogens have devised strategies to control cell death and limit the emission of danger signals from dying cells, thereby avoiding immune recognition. Similarly, cancer cells often escape immunosurveillance owing to defects in the molecular machinery that underlies the release of endogenous adjuvants. Here, we review current knowledge on the mechanisms that underlie the activation of immune responses against dying cells and their pathophysiological relevance.

摘要

免疫原性取决于两个关键因素

抗原性和佐剂活性。外源性或突变抗原的存在解释了为什么感染细胞和恶性细胞能够引发适应性免疫反应,只要这些细胞由于细胞应激和死亡而发出佐剂信号。一些传染性病原体已经设计出策略来控制细胞死亡并限制来自死亡细胞的危险信号的释放,从而避免免疫识别。同样,癌细胞经常逃避免疫监视,这是由于内在佐剂释放的分子机制缺陷所致。在这里,我们综述了目前关于激活针对死亡细胞的免疫反应的机制及其病理生理学相关性的知识。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验